Literature DB >> 2553814

Synergistic effects of phorbol ester and INF-gamma on the induction of indoleamine 2,3-dioxygenase in THP-1 monocytic leukemia cells.

M P Edelstein1, Y Ozaki, D S Duch.   

Abstract

Indoleamine 2,3-dioxygenase (IDO) is a flavin-dependent enzyme which uses superoxide anion as a cosubstrate to catalyze the decyclization of the pyrrole ring of L-tryptophan to form formylkynurenine. This enzyme is induced in some tumor cells after treatment with IFN-gamma. The mechanism of induction of IDO in tumor cells by IFN-gamma was studied in THP-1 human monocytic leukemia cells. Before the addition of IFN-gamma, no IDO could be detected in these cells. Treatment of THP-1 cells with IFN-gamma produced an induction of IDO, with peak activity occurring 72 to 96 h after addition of IFN-gamma. Because phorbol esters are known to induce many enzymes in cells, most likely through the activation of protein kinase C, the effects of PMA on the induction of IDO were determined. PMA potentiated the IFN-gamma-induced elevation of IDO, but by itself, was unable to induce enzyme activity. Maximum induction of IDO in the presence of PMA and IFN-gamma was obtained by preexposure of the cells to PMA for 48 h before the addition of IFN-gamma. Maximum induction of IDO after the addition of IFN-gamma occurred 24 to 48 h after addition of the cytokine to the culture medium. However, the induction of IDO does not appear to be potentiated through the activation of protein kinase C, because the addition of the protein kinase C inhibitor H-7 had no effect on the induction of IDO when the cells were exposed to PMA and IFN-gamma. Moreover, diacylglycerol was unable to replace PMA in these studies. Studies with cAMP and cGMP analogs suggest a role for these compounds in the regulation of IDO expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553814

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Analysis of interferon-gamma resistant mutants that are possibly defective in their signaling mechanism.

Authors:  G S Feng; W Dai; S L Gupta; G Werner-Felmayer; H Wachter; O Takikawa; M W Taylor
Journal:  Mol Gen Genet       Date:  1991-11

2.  The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages.

Authors:  T Jouault; A Bernigaud; G Lepage; P A Trinel; D Poulain
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 3.  The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal.

Authors:  Abdulla A-B Badawy; Gilles Guillemin
Journal:  Int J Tryptophan Res       Date:  2019-08-21

Review 4.  Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?

Authors:  Mary Ew Collier; Shaowei Zhang; Nigel S Scrutton; Flaviano Giorgini
Journal:  Drug Discov Today       Date:  2021-02-18       Impact factor: 7.851

5.  Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma.

Authors:  Annabel Meireson; Liesbeth Ferdinande; Marc Haspeslagh; Benjamin Hennart; Delphine Allorge; Piet Ost; Nora Sundahl; Mathieu Spaas; Annelies Demeyer; Lieve Brochez
Journal:  Front Immunol       Date:  2021-09-07       Impact factor: 7.561

6.  Tracking TRYCAT: A Critical Appraisal of Kynurenine Pathway Quantifications in Blood.

Authors:  Violette Coppens; Robert Verkerk; Manuel Morrens
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

Review 7.  Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy.

Authors:  Xiufang Ren; Songyi Guo; Xiaojiao Guan; Ye Kang; Jiamei Liu; Xianghong Yang
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.